A comprehensive questionnaire including family history, demographics, ethnicity, environmental exposures (alcohol and smoking), medications and relevant medical history was administered. Patients were referred for genetic counselling +/- genetic testing after which EUS was performed. A follow up adverse effects phone call was done

at one week. Cancer risk perception, quality of life and screening specific anxiety was determined pre and post EUS. Results: Forty two individuals completed their first screening program [FPC 33, BRCA2+ 9; M 12, F30; mean age 54 (range 39–78); smokers 4]. Seven individuals had a previous cancer (breast 5, brain 1, prostate 1). EUS results: 14 (33%) had an identifiable focal lesion (12 cysts, 2 hypoechoic areas) and 16 (38%) had “chronic I-BET-762 molecular weight pancreatitis”-like parenchymal changes. The cysts had morphological features compatible with BD-IPMN (mean size 5 mm; range 3–14 mm) and were located predominantly in the body and tail. EUS-guided FNA was done in 1 patient only. No pancreatic malignancy was identified and no patient was referred for surgery. Several incidental extrapancreatic lesions were found: multifocal hepatoma 1, duodenal GIST 1, coeliac disease 1, splenic cyst. There were no significant adverse events post EUS. Thirty seven (87%) of the cohort found genetic counselling

useful. Prior to screening the majority of the cohort were moderately to severely worried about developing PC but following Selleck RG 7204 EUS, 36 (86%) reported reduced anxiety regarding their future cancer risk. Conclusion: HRI have a higher rate of cystic lesions (BD-IPMN) compared

to the general population (33% vs 2.6%1), findings similar to other reported screening programs2. EUS changes of “chronic pancreatitis”, found in 38% of our cohort, are thought to represent imaging correlates of lobular atrophy which is associated with precursor lesions (PanIN, IPMN)3–5.. Genetic counseling was found to be very useful by participants and involvement in a screening program reduced anxiety regarding future cancer risk. However, Edoxaban the natural history of precursor lesions remains unclear and it is uncertain if surveillance programs will ultimately reduce cancer incidence. 1 Lafan T, Horton K Prevalence of unsuspected pancreatic cysts by MDCT, American Journal of Roentgenology.2008;191:802–807. 2 Canto MI, Hruban RH, Fishman EK, et al. Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals. Gastroenterology 2012. 3 Brune K, Hruban R Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol. 2006 Sep;30(9):1067–1076.